Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
for AML
Sites in New Haven +35 more locations
Sponsor: Kura Oncology, Inc.
Sex: All·Age: 18+
Code: NCT06001788·Phase 1·Recruiting·Listed Aug 2023